September 15, 2014

The Department of Justice announced Friday that it filed a motion to hold Bayer in civil contempt for violating a court order in the U.S. District Court for the District of New Jersey.

September 15, 2014

Let’s face it: New products are the lifeblood of this business. If you’re a retailer, that’s why you went to NACDS Total Store Expo. That’s why DSN went to NACDS TSE, too. For two days, our reporters searched the show floor for the very latest and best new products and offerings at NACDS TSE.

August 20, 2014

Excedrin relaunched in the United States in 2013 and is doing well. The brand generated $130 million between its Excedrin tablets and Excedrin Migraine tablets for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

July 24, 2014

The Consumer Healthcare Products Association celebrated the first International Self-Care Day event in the United States.

June 27, 2014

Bayer HealthCare and HealthyWomen on Thursday launched the Family Size Matters initiative to help educate women who are done, or think they may be done, having children about their family planning, including permanent birth control.

June 9, 2014

Bayer last week named Dieter Weinand president of Bayer HealthCare Pharmaceuticals effective Aug. 1.

June 3, 2014

The National Association of Professional Women on Tuesday honored Dawn Jackman as the 2014 Professional Woman of the Year.

May 27, 2014

The May/June 2014 Skin & Itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of AmLactin Cerapeutic Restoring, Cetaphil RestoraDerm Skin Restoring, Olay Advanced Healing Intensive, Curél Intesive Healing, Nivea Extended Moisture, Aveeno 1% Hydrocortisone Anti-itch, Extra Strength Benadryl Itch Stopping and Corizone 10 Anti-itch Ultra Moisturing Creme Plus.

May 16, 2014

These are interesting times to be in the OTC business, Matt Mannelly, Prestige Brands president and CEO, told analysts Thursday.

May 12, 2014

Bayer HealthCare on Monday announced that the Food and Drug Administration approved the company's new indication for Bayer's Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.

May 9, 2014

Bayer agreed to acquire the consumer care business of U.S. pharmaceutical company Merck for a purchase price of $14.2 billion. The OTC acquisition will give Bayer the global No. 2 position in nonprescription products following recently announced consolidations in this growing healthcare industry segment, and will significantly enhance Bayer’s business across multiple therapeutic categories and geographies. Merck's consumer care business includes such leading brands as Claritin, Coppertone and Dr. Scholl’s. Pro forma sales of the combined businesses in 2013 amounted to $7.4 billion with Merck’s business contributing approximately $2.2 billion.

Upon completion of the acquisition, Bayer is expected to achieve global leadership positions in dermatology and gastrointestinals and advance to the No. 2 position in the cold, allergy, sinus and flu category. Bayer will remain No. 2 in nutritionals and No. 3 in analgesics. Overall, the proposed GlaxoSmithKline-Novartis combination represents the largest consumer health business with about 5.7% share, according to reports. The Bayer/Merck combination comes in second with around 4.5% share. McNeil Consumer rounds out the top three globally with a share just above 4%.

May 6, 2014

Bayer on Tuesday agreed to acquire the consumer care business of U.S. pharmaceutical company Merck for a purchase price of $14.2 billion.

May 6, 2014

In a related transaction to Tuesday morning's acquisition of Merck's OTC portfolio, Bayer also agreed to enter into a strategic pharma collaboration in the area of cardiovascular diseases with a focus on sGC modulation.

May 2, 2014

Bayer is negotiating for Merck's consumer health business in a deal worth $14 billion, according to a Bloomberg report published Friday, citing people with knowledge of the matter.

April 23, 2014

Bayer HealthCare on Tuesday announced that the Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for Bayer's investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for the treatment of non-cystic fibrosis bronchiectasis.

April 11, 2014

Ian Read, chairman and CEO of Pfizer, was elected chairman of the Pharmaceutical Research and Manufacturers of America at the trade association’s annual meeting.

March 26, 2014

The March/April 2014 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Children's Claritin Chewable, Children's Allegra Allergy meltable tablets, Children's Benadryl Allergy Liquid, Nasacort Allergy 24HR, Mucinex Allergy, Hyland's 4 Kids Complete Allergy and Similasan Kids Allergy Eye Relief.

March 13, 2014

Bayer HealthCare LLC Animal Health division on Wednesday launched eight flea and tick treatments and control solutions, which are to be sold at pet specialty retail stores.

February 13, 2014

After meeting for two days earlier this week, the Food and Drug Administration's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 16-9 against changing the label of naproxen to highlight a lower cardiovascular risk profile as compared to other NSAIDs, according to published reports.

February 7, 2014

The January/February 2014 Vitamins and Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Vitamints Immune, Centrum Specialist Immune Support, Alive! Children's Multi-Vitamin Gummy, Natrol's Melatonin, VitaMelts Multi, TruBiotics, Align and Culturelle Digestive Health Capsules.

January 29, 2014

A pair of Food and Drug Administration advisory committees will be meeting Feb. 10 to talk about heart risks associated with use of NSAIDs and whether or not Bayer's Aleve (naproxen) carries a lower risk profile than other NSAIDs

January 20, 2014

Bayer's Advantage Multi for Dogs (imidacloprid + moxidectin) received Food and Drug Administration approval as the first-ever treatment for circulating microfilaria in heartworm-positive dogs.

December 26, 2013

Thanks in part to the launch of Alka-Seltzer Fruit Chews, the Alka-Seltzer brand has experienced a resurgence within the antacid tablet category.

November 26, 2013

German chemical and pharmaceutical giant Bayer plans to buy Norwegian drug maker Algeta for $2.4 billion, Algeta confirmed Tuesday.